You're using a free limited version of DrugPatentWatch: Upgrade for Complete Access

Last Updated: January 19, 2025

Drug Price Trends for MELOXICAM


✉ Email this page to a colleague

« Back to Dashboard


Drug Price Trends for MELOXICAM

Average Pharmacy Cost for MELOXICAM

These are average pharmacy acquisition costs (net of discounts) from a US national survey
Drug NameNDCPrice/Unit ($)UnitDate
MELOXICAM 15 MG TABLET 16571-0777-01 0.01840 EACH 2024-12-18
MELOXICAM 15 MG TABLET 16571-0777-10 0.01840 EACH 2024-12-18
MELOXICAM 10 MG CAPSULE 70954-0077-10 10.63239 EACH 2024-12-18
MELOXICAM 7.5 MG TABLET 82009-0129-05 0.01557 EACH 2024-12-18
>Drug Name>NDC>Price/Unit ($)>Unit>Date
Showing 1 to 4 of 4 entries

Best Wholesale Price for MELOXICAM

These are wholesale prices available to the US Federal Government which, by law, must be the best prices available to any customer under comparable terms and conditions
Drug NameVendorNDCCountPrice ($)Price/Unit ($)UnitDatesPrice Type
MELOXICAM 7.5MG TAB Golden State Medical Supply, Inc. 51407-0610-10 1000 31.36 0.03136 EACH 2023-06-15 - 2028-06-14 FSS
MELOXICAM 15MG TAB Golden State Medical Supply, Inc. 51407-0611-10 1000 29.84 0.02984 EACH 2024-04-18 - 2028-09-14 FSS
MELOXICAM 15MG TAB,UD AvKare, LLC 50268-0526-15 5X10UD 5.30 2023-06-15 - 2028-06-14 FSS
MELOXICAM 15MG TAB Golden State Medical Supply, Inc. 51407-0611-90 90 2.95 0.03278 EACH 2023-06-15 - 2028-06-14 FSS
>Drug Name>Vendor>NDC>Count>Price ($)>Price/Unit ($)>Unit>Dates>Price Type
Price type key: Federal Supply Schedule (FSS): generally available to all Federal Govt agencies / 'BIG4' prices: VA, DoD, Public Health & Coast Guard only / National Contracts (NC): Available to specific agencies
Showing 1 to 4 of 4 entries

Market Analysis and Price Projections for Meloxicam

Introduction to Meloxicam

Meloxicam is a non-steroidal anti-inflammatory drug (NSAID) widely used for the treatment of pain and inflammation associated with conditions such as osteoarthritis, rheumatoid arthritis, and other musculoskeletal disorders. Its efficacy in managing chronic pain with fewer gastrointestinal side effects compared to other NSAIDs has made it a preferred choice for both patients and healthcare professionals.

Global Market Size and Growth

The global meloxicam market is anticipated to experience significant growth over the coming years. Here are some key projections:

  • By 2036, the meloxicam market size is expected to reach USD 47 billion, growing at a Compound Annual Growth Rate (CAGR) of around 5% from 2024 to 2036. In 2023, the market size was over USD 7 billion[1].
  • Another report estimates that the meloxicam market was valued at USD 2.8 billion in 2023 and is expected to reach USD 4.2 billion by 2031, growing at a CAGR of 4.5% from 2024 to 2031[3].

Key Growth Drivers

Increasing Prevalence of Chronic Pain and Arthritis

The rising prevalence of osteoarthritis, rheumatoid arthritis, and juvenile rheumatoid arthritis is a primary driver of the meloxicam market. As populations age, these conditions become more common, leading to a higher demand for effective pain relief medications. For instance, according to the World Health Organization, 60% of those with osteoarthritis are female and 73% are older than 55[1].

Shift Toward Safer Pain Management Options

There is a noticeable shift towards safer alternatives to opioids due to growing concerns over their side effects. Meloxicam, with its effective pain management and fewer side effects, is becoming a preferred option for long-term use in chronic conditions[4].

Development of Novel Formulations

Pharmaceutical companies are investing in research and development to create innovative formulations of meloxicam, such as extended-release tablets, transdermal patches, and orally disintegrating tablets. These advancements are expected to enhance the drug's market reach and appeal to a wider patient population[4].

Increasing Use in Veterinary Medicine

Meloxicam is also widely used in veterinary medicine to treat pain and inflammation in animals, particularly for managing osteoarthritis and post-surgical pain in dogs, cats, and other animals. This expanding application contributes to the overall market growth[4].

Growing Awareness and Accessibility

The rising awareness of the benefits of meloxicam, combined with increased accessibility through online pharmacies and generic drug manufacturers, is making it easier for patients to obtain this medication. The availability of cost-effective generic versions has made meloxicam more affordable, increasing its adoption among patients across different regions[4].

Market Segmentation

By Disease Type

  • The osteoarthritis segment is estimated to account for the largest revenue share of 40% by the end of 2036, driven by the rise in prevalence and consumer awareness of treatment options[1].

By Drug Type

  • The combination drug segment is set to grow significantly by 2036, as these drugs can treat multiple conditions simultaneously, enhancing their demand[1].

Regional Market Analysis

North America

  • The meloxicam market in North America is anticipated to account for the largest revenue share of 33% by the end of the forecast period. This growth is driven by an increasing number of arthritis and other chronic pain disease patients in the region, along with escalating research and development activities and robust healthcare infrastructure[1].

Asia Pacific

  • The meloxicam market in the Asia Pacific region is expected to account for a notable revenue share during the forecast period. This growth is attributed to the high product demand due to the growing aging population and the increasing incidence of osteoarthritis, rheumatoid arthritis, and other inflammatory conditions. Favorable reimbursement policies for generic drugs in the region also contribute to market growth[1].

Price Projections and Affordability

Current Pricing

  • The cost for meloxicam varies based on the dosage and form. For example, a 30-day supply of meloxicam 15 mg oral tablets can cost around $11, depending on the pharmacy and the use of discount cards[2].

Generic and Brand Pricing

  • Generic versions of meloxicam are available and are generally more affordable than brand-name versions. The availability of generic equivalents improves accessibility and reduces prices, driving market expansion[3].

Challenges and Limitations

Market Competition

  • The meloxicam market faces competition from other NSAIDs and pain management medications, which can impact market growth[5].

Side Effects

  • Despite its safety profile, meloxicam can have severe side effects such as ulcers and dizziness, which may hamper market growth[5].

Key Takeaways

  • The global meloxicam market is expected to grow significantly due to the increasing prevalence of chronic pain and arthritis.
  • The market is driven by the shift towards safer pain management options, development of novel formulations, and growing awareness and accessibility.
  • North America and the Asia Pacific region are key markets, driven by demographic factors and healthcare infrastructure.
  • Generic versions and favorable reimbursement policies are making meloxicam more affordable and accessible.

FAQs

Q: What is the projected market size of meloxicam by 2036?

A: The meloxicam market size is anticipated to reach USD 47 billion by the end of 2036, growing at a CAGR of around 5% from 2024 to 2036[1].

Q: What are the primary drivers of the meloxicam market?

A: The primary drivers include the increasing prevalence of chronic pain and arthritis, a shift towards safer pain management options, and the development of novel formulations[4].

Q: Which region is expected to account for the largest revenue share in the meloxicam market?

A: North America is anticipated to account for the largest revenue share of 33% by the end of the forecast period[1].

Q: How does the use of meloxicam in veterinary medicine impact the market?

A: The use of meloxicam in veterinary medicine contributes to the overall market growth as it is widely used to treat pain and inflammation in animals[4].

Q: What are the potential challenges facing the meloxicam market?

A: The market faces challenges such as competition from other NSAIDs, severe side effects, and market competition among players[5].

Sources

  1. Research Nester, "Meloxicam Market Size - Global Forecast Report 2036", November 2, 2023.
  2. Drugs.com, "Meloxicam Prices, Coupons, Copay Cards & Patient Assistance".
  3. Market Research Intellect, "Meloxicam Drug Market Size, Share | Industry Research Report 2031".
  4. Market Research Intellect, "Meloxicam Drug Sales: Insights into Growth Trends and Market Evolution", October 1, 2024.
  5. Data Bridge Market Research, "Global Meloxicam Market - Industry Trends and Forecast to 2028".

More… ↓

⤷  Subscribe

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.